<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03124381</url>
  </required_header>
  <id_info>
    <org_study_id>PS-170103145529-SACT</org_study_id>
    <nct_id>NCT03124381</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate the Efficacy and Tolerance of 2 Acne Treatment Regimens on Subjects With Mild to Moderate Acne</brief_title>
  <official_title>A Multi-Center, Evaluator Blinded, Randomized Clinical Study to Evaluate the Efficacy and Tolerance of Two Acne Treatment Regimens on Subjects With Mild to Moderate Acne Vulgaris</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johnson &amp; Johnson Consumer Inc. (J&amp;JCI)</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johnson &amp; Johnson Consumer and Personal Products Worldwide</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare two different acne treatment regimens for the treatment of acne. Half
      of participants will receive a cleanser and a light therapy mask, while half of the
      participants will receive a cleanser, a light therapy topical gel-cream, and a light therapy
      mask.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acne vulgaris is a common chronic skin disease involving blockage and/or inflammation of the
      hair follicles and their accompany sebaceous glands.

      Research has shown the benefits of red and blue light therapy in the treatment of mild to
      moderate acne, with red and blue light shown to target acne-causing bacteria and have an
      effect on inflammation reduction.

      Light-based therapies have been used successfully to treat dermatological conditions since
      the early 1900s, with various parts of the electromagnetic spectrum (i.e. ultraviolet [UV],
      visible, near-infrared, etc.) demonstrating different benefits. Light-emitting diodes (LEDs)
      offer delivery of light to the skin in a gentler manner as compared to light delivered by
      lasers, primarily due to the lower energy output. It has been reported that LEDs do not
      deliver enough power to damage tissues and do not have the same risk of accidental eye damage
      that lasers do. Visible-LED light therapy has been deemed a non-significant risk by the U.S.
      Food and Drug Administration (FDA) and has been approved for use in humans.

      It is well established in the literature that visible light penetration into the epidermal
      and dermal layers of human skin is primarily governed by absorption and scattering events,
      with the latter being the more impactful of the two. Visible light penetration into human
      skin can be increased by reducing scattering. This can be accomplished by temporary hydrogen
      bonding disruption, which leads to the reversible rearrangement of epidermal and dermal
      structures that cause scattering. Glycerol (i.e. glycerin) is hypothesized to generate the
      level of hydrogen bonding disruption described above, and therefore will be investigated in
      the present study.

      This study will look to evaluate and then compare the acne clearing efficacy and tolerance of
      two different acne treatment regimens - a cleanser used with a currently marketed red and
      blue light acne light therapy mask alone vs. the cleanser used with the same mask in
      conjunction with a light therapy topical gel-cream - to determine the efficacy of these
      treatments and then to assess if the efficacy of the light therapy mask used with the topical
      gel-cream treatment is non-inferior to the mask alone in the reduction of lesions in mild to
      moderate acne. If non-inferiority is demonstrated, the mask with topical gel-cream treatment
      will be further assessed for its superiority to the mask alone.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 8, 2017</start_date>
  <completion_date type="Actual">September 6, 2017</completion_date>
  <primary_completion_date type="Actual">September 6, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
    <masking_description>Evaluator-blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Global Face Total Lesion Count - Percent Change - Baseline to Week 12</measure>
    <time_frame>Baseline and Week 12</time_frame>
    <description>Percent change from baseline in global face total lesion count at Week 12</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Global Face Total Lesion Count - Percent Change - Baseline to Week 2</measure>
    <time_frame>Baseline and Week 2</time_frame>
    <description>Percent change from baseline in global face total lesion count at Week 2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Face Total Lesion Count - Percent Change - Baseline to Week 4</measure>
    <time_frame>Baseline and Week 4</time_frame>
    <description>Percent change from baseline in global face total lesion count at Week 4</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Face Total Lesion Count - Percent Change - Baseline to Week 8</measure>
    <time_frame>Baseline and Week 8</time_frame>
    <description>Percent change from baseline in global face total lesion count at Week 8</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Face Total Lesion Count - Percent Change From Baseline to the Mean of All Visits</measure>
    <time_frame>Baseline to Week 2, Week 4, Week 8, and Week 12</time_frame>
    <description>Global face total lesion counts are averaged across all applicable post-baseline visits (Week 2, Week 4, Week 8, and Week 12). Percent change from baseline to the mean is then calculated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Face Total Lesion Count - Percent Change From Baseline to the Mean of Week 2 and Week 4</measure>
    <time_frame>Baseline to Week 2 and Week 4</time_frame>
    <description>Global face total lesion counts are averaged across Week 2 and Week 4. Percent change from baseline to the mean is then calculated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Face Total Lesion Count - Percent Change From Baseline to the Mean of Week 4 and Week 8</measure>
    <time_frame>Baseline to Week 4 and Week 8</time_frame>
    <description>Global face total lesion counts are averaged across Week 4 and Week 8. Percent change from baseline to the mean is then calculated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Face Total Lesion Count - Percent Change From Baseline to the Mean of Week 8 and Week 12</measure>
    <time_frame>Baseline to Week 8 and Week 12</time_frame>
    <description>Global face total lesion counts are averaged across Week 8 and Week 12. Percent change from baseline to the mean is then calculated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Face Open Comedones Count - Week 2</measure>
    <time_frame>2 weeks</time_frame>
    <description>Open comedones count on global face - Week 2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Face Open Comedones Count - Week 4</measure>
    <time_frame>4 weeks</time_frame>
    <description>Open comedones count on global face - Week 4</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Face Open Comedones Count - Week 8</measure>
    <time_frame>8 weeks</time_frame>
    <description>Open comedones count on global face - Week 8</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Face Open Comedones Count - Week 12</measure>
    <time_frame>12 weeks</time_frame>
    <description>Open comedones count on global face - Week 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Face Closed Comedones Count - Week 2</measure>
    <time_frame>2 weeks</time_frame>
    <description>Closed comedones count on global face - Week 2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Face Closed Comedones Count - Week 4</measure>
    <time_frame>4 weeks</time_frame>
    <description>Closed comedones count on global face - Week 4</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Face Closed Comedones Count - Week 8</measure>
    <time_frame>8 weeks</time_frame>
    <description>Closed comedones count on global face - Week 8</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Face Closed Comedones Count - Week 12</measure>
    <time_frame>12 weeks</time_frame>
    <description>Closed comedones count on global face - Week 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Face Inflammatory Lesion Count - Week 2</measure>
    <time_frame>2 weeks</time_frame>
    <description>Papules and pustules counted together</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Face Inflammatory Lesion Count - Week 4</measure>
    <time_frame>4 weeks</time_frame>
    <description>Papules and pustules counted together</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Face Inflammatory Lesion Count - Week 8</measure>
    <time_frame>8 weeks</time_frame>
    <description>Papules and pustules counted together</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Face Inflammatory Lesion Count - Week 12</measure>
    <time_frame>12 weeks</time_frame>
    <description>Papules and pustules counted together</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Face Non-Inflammatory Lesion Count - Week 2</measure>
    <time_frame>2 weeks</time_frame>
    <description>Sum of open comedones and closed comedones</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Face Non-Inflammatory Lesion Count - Week 4</measure>
    <time_frame>4 weeks</time_frame>
    <description>Sum of open comedones and closed comedones</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Face Non-Inflammatory Lesion Count - Week 8</measure>
    <time_frame>8 weeks</time_frame>
    <description>Sum of open comedones and closed comedones</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Face Non-Inflammatory Lesion Count - Week 12</measure>
    <time_frame>12 weeks</time_frame>
    <description>Sum of open comedones and closed comedones</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Face Total Lesion Count - Week 2</measure>
    <time_frame>2 weeks</time_frame>
    <description>Sum of inflammatory and non-inflammatory lesions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Face Total Lesion Count - Week 4</measure>
    <time_frame>4 weeks</time_frame>
    <description>Sum of inflammatory and non-inflammatory lesions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Face Total Lesion Count - Week 8</measure>
    <time_frame>8 weeks</time_frame>
    <description>Sum of inflammatory and non-inflammatory lesions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Face Total Lesion Count - Week 12</measure>
    <time_frame>12 weeks</time_frame>
    <description>Sum of inflammatory and non-inflammatory lesions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Investigator Global Acne Assessment - Week 1</measure>
    <time_frame>1 week</time_frame>
    <description>Investigator Global Acne Assessment using Modified Cooke's Scale - Week 1. Modified Cooke's scale ranges from 0 = clear/no acne to 5 = very severe acne. Half-points are allowed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Investigator Global Acne Assessment - Week 2</measure>
    <time_frame>2 weeks</time_frame>
    <description>Investigator Global Acne Assessment using Modified Cooke's Scale - Week 2. Modified Cooke's scale ranges from 0 = clear/no acne to 5 = very severe acne. Half-points are allowed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Investigator Global Acne Assessment - Week 4</measure>
    <time_frame>4 weeks</time_frame>
    <description>Investigator Global Acne Assessment using Modified Cooke's Scale - Week 4. Modified Cooke's scale ranges from 0 = clear/no acne to 5 = very severe acne. Half-points are allowed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Investigator Global Acne Assessment - Week 8</measure>
    <time_frame>8 weeks</time_frame>
    <description>Investigator Global Acne Assessment using Modified Cooke's Scale - Week 8. Modified Cooke's scale ranges from 0 = clear/no acne to 5 = very severe acne. Half-points are allowed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Investigator Global Acne Assessment - Week 12</measure>
    <time_frame>12 weeks</time_frame>
    <description>Investigator Global Acne Assessment using Modified Cooke's Scale - Week 12. Modified Cooke's scale ranges from 0 = clear/no acne to 5 = very severe acne. Half-points are allowed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Redness of Inflammatory Lesions - Week 1</measure>
    <time_frame>1 week</time_frame>
    <description>Additional investigator efficacy assessment. 0-9 scale where 0 = no redness associated with the inflammatory lesions; 9 = overall, inflammatory lesions exhibit severe degree of redness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Redness of Inflammatory Lesions - Week 2</measure>
    <time_frame>2 weeks</time_frame>
    <description>Additional investigator efficacy assessment. 0-9 scale where 0 = no redness associated with the inflammatory lesions; 9 = overall, inflammatory lesions exhibit severe degree of redness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Redness of Inflammatory Lesions - Week 4</measure>
    <time_frame>4 weeks</time_frame>
    <description>Additional investigator efficacy assessment. 0-9 scale where 0 = no redness associated with the inflammatory lesions; 9 = overall, inflammatory lesions exhibit severe degree of redness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Redness of Inflammatory Lesions - Week 8</measure>
    <time_frame>8 weeks</time_frame>
    <description>Additional investigator efficacy assessment. 0-9 scale where 0 = no redness associated with the inflammatory lesions; 9 = overall, inflammatory lesions exhibit severe degree of redness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Redness of Inflammatory Lesions - Week 12</measure>
    <time_frame>12 weeks</time_frame>
    <description>Additional investigator efficacy assessment. 0-9 scale where 0 = no redness associated with the inflammatory lesions; 9 = overall, inflammatory lesions exhibit severe degree of redness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Size of Inflammatory Lesions - Week 1</measure>
    <time_frame>1 week</time_frame>
    <description>Additional investigator efficacy assessment. 0-9 scale where 0 = no longer visible; 9 = overall size is very large</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Size of Inflammatory Lesions - Week 2</measure>
    <time_frame>2 weeks</time_frame>
    <description>Additional investigator efficacy assessment. Additional investigator efficacy assessment. 0-9 scale where 0 = no longer visible; 9 = overall size is very large</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Size of Inflammatory Lesions - Week 4</measure>
    <time_frame>4 weeks</time_frame>
    <description>Additional investigator efficacy assessment. Additional investigator efficacy assessment. 0-9 scale where 0 = no longer visible; 9 = overall size is very large</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Size of Inflammatory Lesions - Week 8</measure>
    <time_frame>8 weeks</time_frame>
    <description>Additional investigator efficacy assessment. Additional investigator efficacy assessment. 0-9 scale where 0 = no longer visible; 9 = overall size is very large.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Size of Inflammatory Lesions - Week 12</measure>
    <time_frame>12 weeks</time_frame>
    <description>Additional investigator efficacy assessment. Additional investigator efficacy assessment. 0-9 scale where 0 = no longer visible; 9 = overall size is very large</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">126</enrollment>
  <condition>Acne Vulgaris</condition>
  <arm_group>
    <arm_group_label>Acne Mask</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cleanser, Acne Mask</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Gel-Cream + Acne Mask</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cleanser, Gel-Cream, Acne Mask</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cleanser, Acne Mask</intervention_name>
    <description>A facial cleanser will be used twice daily (morning and evening). The light therapy mask will be used for 10 minutes in the evening after washing/drying the face.</description>
    <arm_group_label>Acne Mask</arm_group_label>
    <other_name>Light Therapy Mask</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cleanser, Gel-Cream, Acne Mask</intervention_name>
    <description>A facial cleanser will be used twice daily (morning and evening). In the evening after cleansing, the gel-cream will be applied full face and allowed to dry before the light therapy mask is used for 10 minutes.</description>
    <arm_group_label>Gel-Cream + Acne Mask</arm_group_label>
    <other_name>Light Therapy Mask</other_name>
    <other_name>Light Therapy Topical Gel-Cream</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Has mild to moderate facial acne

          -  Has 10-100 blackheads/whiteheads, 10-50 pimples, no cysts, and up to 2 large, hard,
             painful bumps (nodules)

          -  Able to read, write, speak, and understand English

          -  In general good health

          -  Must agree to practice a medically acceptable form of birth control.

          -  Intends to complete the study and willing to follow all study instructions.

        Exclusion Criteria:

          -  Very sensitive skin or allergies/sensitivity to skincare products or the test product
             ingredients.

          -  Has a light or photosensitivity disorder or another medical condition that could
             increase risk to the subject or confuse the study results

          -  Is using medication that makes skin more sensitive to light

          -  Has severe acne or a pre-existing facial skin condition other than mild to moderate
             acne

          -  has an immune deficiency disorder

          -  has been using a product or medication that the stuff investigator determines will
             increase health risk to the subject or confuse the study results

          -  Females that are pregnant, nursing, or planning to become pregnant

          -  Males with a female partner who is pregnant or planning to become pregnant

          -  Has excessive facial hair

          -  Is participating in another study within past 4 weeks

          -  Is related to the Sponsor, Investigator, or Study Site
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alicia Bucko, D.O.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Academic Dermatology Associates</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lily Jiang, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Thomas J. Stephens &amp; Associates, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Academic Dermatology Associates</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Thomas J. Stephens and Associates, Inc.</name>
      <address>
        <city>Richardson</city>
        <state>Texas</state>
        <zip>75081</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Ashkenazi H, Malik Z, Harth Y, Nitzan Y. Eradication of Propionibacterium acnes by its endogenic porphyrins after illumination with high intensity blue light. FEMS Immunol Med Microbiol. 2003 Jan 21;35(1):17-24.</citation>
    <PMID>12589953</PMID>
  </reference>
  <reference>
    <citation>Kjeldstad B. Photoinactivation of Propionibacterium acnes by near-ultraviolet light. Z Naturforsch C Biosci. 1984 Mar-Apr;39(3-4):300-2.</citation>
    <PMID>6730638</PMID>
  </reference>
  <reference>
    <citation>Roelandts R. A new light on Niels Finsen, a century after his Nobel Prize. Photodermatol Photoimmunol Photomed. 2005 Jun;21(3):115-7.</citation>
    <PMID>15888126</PMID>
  </reference>
  <reference>
    <citation>Barolet D. Light-emitting diodes (LEDs) in dermatology. Semin Cutan Med Surg. 2008 Dec;27(4):227-38. doi: 10.1016/j.sder.2008.08.003. Review.</citation>
    <PMID>19150294</PMID>
  </reference>
  <reference>
    <citation>Salomatina E, Jiang B, Novak J, Yaroslavsky AN. Optical properties of normal and cancerous human skin in the visible and near-infrared spectral range. J Biomed Opt. 2006 Nov-Dec;11(6):064026.</citation>
    <PMID>17212549</PMID>
  </reference>
  <reference>
    <citation>Bashkatov, AN, et al. Optical properties of melanin in the skin and skin-like phantoms. Proc. of SPIE, 4162: 219-226, 2000.</citation>
  </reference>
  <reference>
    <citation>Bashkatov, AN, et al. Optical properties of human skin, subcutaneous and mucous tissues in the wavelength range from 400 to 2000 nm. J Phys D: Appl Phys, 38: 2543-2555, 2005.</citation>
  </reference>
  <reference>
    <citation>Jacques SL. Optical properties of biological tissues: a review. Phys Med Biol. 2013 Jun 7;58(11):R37-61. doi: 10.1088/0031-9155/58/11/R37. Epub 2013 May 10. Review. Erratum in: Phys Med Biol. 2013 Jul 21;58(14):5007-8.</citation>
    <PMID>23666068</PMID>
  </reference>
  <reference>
    <citation>Lamouche G, Kennedy BF, Kennedy KM, Bisaillon CE, Curatolo A, Campbell G, Pazos V, Sampson DD. Review of tissue simulating phantoms with controllable optical, mechanical and structural properties for use in optical coherence tomography. Biomed Opt Express. 2012 Jun 1;3(6):1381-98. doi: 10.1364/BOE.3.001381. Epub 2012 May 15.</citation>
    <PMID>22741083</PMID>
  </reference>
  <reference>
    <citation>Pogue BW, Patterson MS. Review of tissue simulating phantoms for optical spectroscopy, imaging and dosimetry. J Biomed Opt. 2006 Jul-Aug;11(4):041102. Review.</citation>
    <PMID>16965130</PMID>
  </reference>
  <reference>
    <citation>Hirshburg J, Choi B, Nelson JS, Yeh AT. Correlation between collagen solubility and skin optical clearing using sugars. Lasers Surg Med. 2007 Feb;39(2):140-4.</citation>
    <PMID>17311267</PMID>
  </reference>
  <reference>
    <citation>Wiegand, B, Luedtke, K, Rapp, SR. Acne Profile. Johnson &amp; Johnson, One Johnson &amp; Johnson Plaza, New Brunswick, NJ 08933-7003, assignee. Patent US 2006/0008484 A1. 12 Jan. 2006. Print.</citation>
  </reference>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>April 3, 2017</study_first_submitted>
  <study_first_submitted_qc>April 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 21, 2017</study_first_posted>
  <results_first_submitted>September 4, 2018</results_first_submitted>
  <results_first_submitted_qc>October 11, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">November 9, 2018</results_first_posted>
  <last_update_submitted>February 13, 2019</last_update_submitted>
  <last_update_submitted_qc>February 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acne</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acne Vulgaris</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 19, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/81/NCT03124381/SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>March 6, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/81/NCT03124381/Prot_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Gel-Cream + Acne Mask</title>
          <description>Cleanser, Gel-Cream, Acne Mask</description>
        </group>
        <group group_id="P2">
          <title>Acne Mask</title>
          <description>Cleanser, Acne Mask</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="65"/>
                <participants group_id="P2" count="61"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="56"/>
                <participants group_id="P2" count="55"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Non-Compliance with Study Treatment</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Gel-Cream + Acne Mask</title>
          <description>Cleanser, Gel-Cream, Acne Mask</description>
        </group>
        <group group_id="B2">
          <title>Acne Mask</title>
          <description>Cleanser, Acne Mask</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="65"/>
            <count group_id="B2" value="61"/>
            <count group_id="B3" value="126"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18.8" spread="6.03"/>
                    <measurement group_id="B2" value="20.0" spread="7.65"/>
                    <measurement group_id="B3" value="19.4" spread="6.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="32"/>
                    <measurement group_id="B3" value="70"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="48"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="78"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="47"/>
                    <measurement group_id="B2" value="47"/>
                    <measurement group_id="B3" value="94"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Skin Sensitivity</title>
          <description>Self-perceived skin sensitivity. Do you consider your skin to be sensitive...none of the time, some of the time, most of the time, all of the time</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>None of the Time</title>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="40"/>
                    <measurement group_id="B3" value="78"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Some of the Time</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="39"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Most of the Time</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>All of the Time</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Fitzpatrick Skin Type</title>
          <description>Description:Measure of skin type characteristics, including sensitivity to burning/tanning. Ranging from I to VI, where I = White; very fair; red or blonde hair; blue eyes; freckles; Always burns easily; never tans and VI = Black; black hair, black eyes, black skin; Never burns; deeply pigmented</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>I</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>II</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="52"/>
                  </measurement_list>
                </category>
                <category>
                  <title>III</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
                <category>
                  <title>IV</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>V</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>VI</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Global Face Total Lesion Count - Percent Change - Baseline to Week 12</title>
        <description>Percent change from baseline in global face total lesion count at Week 12</description>
        <time_frame>Baseline and Week 12</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. Missing values were imputed by carrying forward the last observed post-baseline score. There was no post-baseline data to carry forward for three subjects.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Global Face Total Lesion Count - Percent Change - Baseline to Week 12</title>
          <description>Percent change from baseline in global face total lesion count at Week 12</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. Missing values were imputed by carrying forward the last observed post-baseline score. There was no post-baseline data to carry forward for three subjects.</population>
          <units>Percent Change in Lesions</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-42.64" spread="31.817"/>
                    <measurement group_id="O2" value="-47.80" spread="30.209"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Non-inferiority test performed after significance vs. baseline confirmed for each cell. The null hypothesis for the non-inferiority test was H0: A-B≥15%, where A and B are the mean percent change at Week 12 of global face total acne lesion count of the Gel-Cream + Acne Mask cell and Acne Mask cell, respectively.</groups_desc>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority concluded if the upper bound of the two-sided 95% confidence interval (based on ANCOVA) is less than 15 percentage points. Terms for treatment, gender, center as factors and baseline as covariate.</non_inferiority_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>3.19</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>5.164</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-7.04</ci_lower_limit>
            <ci_upper_limit>13.42</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Superiority test performed after non-inferiority confirmed as described above. The null hypothesis for the superiority test was H0: A−B = 0, where A and B are the mean percent change at Week 12 of global face total acne lesion count of the Acne Mask and the Gel-Cream + Acne Mask cell, respectively.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Superiority concluded if the upper bound of the two-sided 95% confidence interval of the treatment difference is less than 0. Terms for treatment, gender, and center as factors and baseline score as covariate.</non_inferiority_desc>
            <p_value>0.538</p_value>
            <method>ANCOVA</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>3.19</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>5.164</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-7.04</ci_lower_limit>
            <ci_upper_limit>13.42</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Global Face Total Lesion Count - Percent Change - Baseline to Week 2</title>
        <description>Percent change from baseline in global face total lesion count at Week 2</description>
        <time_frame>Baseline and Week 2</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Global Face Total Lesion Count - Percent Change - Baseline to Week 2</title>
          <description>Percent change from baseline in global face total lesion count at Week 2</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Percent Change in Lesions</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-24.16" spread="25.646"/>
                    <measurement group_id="O2" value="-27.97" spread="21.330"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Global Face Total Lesion Count - Percent Change - Baseline to Week 4</title>
        <description>Percent change from baseline in global face total lesion count at Week 4</description>
        <time_frame>Baseline and Week 4</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Global Face Total Lesion Count - Percent Change - Baseline to Week 4</title>
          <description>Percent change from baseline in global face total lesion count at Week 4</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Percent Change in Lesions</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
                <count group_id="O2" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-29.78" spread="27.388"/>
                    <measurement group_id="O2" value="-38.25" spread="22.729"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Global Face Total Lesion Count - Percent Change - Baseline to Week 8</title>
        <description>Percent change from baseline in global face total lesion count at Week 8</description>
        <time_frame>Baseline and Week 8</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Global Face Total Lesion Count - Percent Change - Baseline to Week 8</title>
          <description>Percent change from baseline in global face total lesion count at Week 8</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Percent Change in Lesions</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="57"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-39.81" spread="26.192"/>
                    <measurement group_id="O2" value="-45.86" spread="23.369"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Global Face Total Lesion Count - Percent Change From Baseline to the Mean of All Visits</title>
        <description>Global face total lesion counts are averaged across all applicable post-baseline visits (Week 2, Week 4, Week 8, and Week 12). Percent change from baseline to the mean is then calculated.</description>
        <time_frame>Baseline to Week 2, Week 4, Week 8, and Week 12</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Global Face Total Lesion Count - Percent Change From Baseline to the Mean of All Visits</title>
          <description>Global face total lesion counts are averaged across all applicable post-baseline visits (Week 2, Week 4, Week 8, and Week 12). Percent change from baseline to the mean is then calculated.</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Percent Change in Lesions</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-33.68" spread="24.212"/>
                    <measurement group_id="O2" value="-39.79" spread="20.754"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Global Face Total Lesion Count - Percent Change From Baseline to the Mean of Week 2 and Week 4</title>
        <description>Global face total lesion counts are averaged across Week 2 and Week 4. Percent change from baseline to the mean is then calculated.</description>
        <time_frame>Baseline to Week 2 and Week 4</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Global Face Total Lesion Count - Percent Change From Baseline to the Mean of Week 2 and Week 4</title>
          <description>Global face total lesion counts are averaged across Week 2 and Week 4. Percent change from baseline to the mean is then calculated.</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Percent Change in Lesions</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-26.95" spread="24.419"/>
                    <measurement group_id="O2" value="-33.01" spread="19.648"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Global Face Total Lesion Count - Percent Change From Baseline to the Mean of Week 4 and Week 8</title>
        <description>Global face total lesion counts are averaged across Week 4 and Week 8. Percent change from baseline to the mean is then calculated.</description>
        <time_frame>Baseline to Week 4 and Week 8</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Global Face Total Lesion Count - Percent Change From Baseline to the Mean of Week 4 and Week 8</title>
          <description>Global face total lesion counts are averaged across Week 4 and Week 8. Percent change from baseline to the mean is then calculated.</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations</population>
          <units>Percent Change in Lesions</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
                <count group_id="O2" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-34.34" spread="25.438"/>
                    <measurement group_id="O2" value="-42.09" spread="21.082"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Global Face Total Lesion Count - Percent Change From Baseline to the Mean of Week 8 and Week 12</title>
        <description>Global face total lesion counts are averaged across Week 8 and Week 12. Percent change from baseline to the mean is then calculated.</description>
        <time_frame>Baseline to Week 8 and Week 12</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Global Face Total Lesion Count - Percent Change From Baseline to the Mean of Week 8 and Week 12</title>
          <description>Global face total lesion counts are averaged across Week 8 and Week 12. Percent change from baseline to the mean is then calculated.</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Percent Change in Lesions</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="58"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-41.73" spread="27.472"/>
                    <measurement group_id="O2" value="-47.25" spread="46.201"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Global Face Open Comedones Count - Week 2</title>
        <description>Open comedones count on global face - Week 2</description>
        <time_frame>2 weeks</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Global Face Open Comedones Count - Week 2</title>
          <description>Open comedones count on global face - Week 2</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Open Comedones</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.1" spread="10.68"/>
                    <measurement group_id="O2" value="5.6" spread="6.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Global Face Open Comedones Count - Week 4</title>
        <description>Open comedones count on global face - Week 4</description>
        <time_frame>4 weeks</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Global Face Open Comedones Count - Week 4</title>
          <description>Open comedones count on global face - Week 4</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Open Comedones</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
                <count group_id="O2" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.9" spread="10.37"/>
                    <measurement group_id="O2" value="5.3" spread="6.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Global Face Open Comedones Count - Week 8</title>
        <description>Open comedones count on global face - Week 8</description>
        <time_frame>8 weeks</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Global Face Open Comedones Count - Week 8</title>
          <description>Open comedones count on global face - Week 8</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Open Comedones</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="57"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.1" spread="7.83"/>
                    <measurement group_id="O2" value="4.5" spread="6.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Global Face Open Comedones Count - Week 12</title>
        <description>Open comedones count on global face - Week 12</description>
        <time_frame>12 weeks</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Global Face Open Comedones Count - Week 12</title>
          <description>Open comedones count on global face - Week 12</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Open Comedones</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.6" spread="5.2"/>
                    <measurement group_id="O2" value="3.7" spread="6.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Global Face Closed Comedones Count - Week 2</title>
        <description>Closed comedones count on global face - Week 2</description>
        <time_frame>2 weeks</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Global Face Closed Comedones Count - Week 2</title>
          <description>Closed comedones count on global face - Week 2</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Closed Comedones</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.7" spread="10.66"/>
                    <measurement group_id="O2" value="12.7" spread="9.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Global Face Closed Comedones Count - Week 4</title>
        <description>Closed comedones count on global face - Week 4</description>
        <time_frame>4 weeks</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Global Face Closed Comedones Count - Week 4</title>
          <description>Closed comedones count on global face - Week 4</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Closed Comedones</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
                <count group_id="O2" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.1" spread="11.69"/>
                    <measurement group_id="O2" value="10.9" spread="7.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Global Face Closed Comedones Count - Week 8</title>
        <description>Closed comedones count on global face - Week 8</description>
        <time_frame>8 weeks</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Global Face Closed Comedones Count - Week 8</title>
          <description>Closed comedones count on global face - Week 8</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Closed Comedones</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="57"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.7" spread="10.38"/>
                    <measurement group_id="O2" value="10.3" spread="7.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Global Face Closed Comedones Count - Week 12</title>
        <description>Closed comedones count on global face - Week 12</description>
        <time_frame>12 weeks</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Global Face Closed Comedones Count - Week 12</title>
          <description>Closed comedones count on global face - Week 12</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Closed Comedones</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.9" spread="10.01"/>
                    <measurement group_id="O2" value="10.2" spread="9.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Global Face Inflammatory Lesion Count - Week 2</title>
        <description>Papules and pustules counted together</description>
        <time_frame>2 weeks</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Global Face Inflammatory Lesion Count - Week 2</title>
          <description>Papules and pustules counted together</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Inflammatory Lesions</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.1" spread="8.23"/>
                    <measurement group_id="O2" value="10.3" spread="5.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Global Face Inflammatory Lesion Count - Week 4</title>
        <description>Papules and pustules counted together</description>
        <time_frame>4 weeks</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Global Face Inflammatory Lesion Count - Week 4</title>
          <description>Papules and pustules counted together</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Inflammatory Lesions</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
                <count group_id="O2" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.8" spread="7.56"/>
                    <measurement group_id="O2" value="9.1" spread="6.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Global Face Inflammatory Lesion Count - Week 8</title>
        <description>Papules and pustules counted together</description>
        <time_frame>8 weeks</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Global Face Inflammatory Lesion Count - Week 8</title>
          <description>Papules and pustules counted together</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Inflammatory Lesions</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="57"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.9" spread="6.85"/>
                    <measurement group_id="O2" value="7.8" spread="5.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Global Face Inflammatory Lesion Count - Week 12</title>
        <description>Papules and pustules counted together</description>
        <time_frame>12 weeks</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Global Face Inflammatory Lesion Count - Week 12</title>
          <description>Papules and pustules counted together</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Inflammatory Lesions</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.7" spread="7.19"/>
                    <measurement group_id="O2" value="7.7" spread="6.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Global Face Non-Inflammatory Lesion Count - Week 2</title>
        <description>Sum of open comedones and closed comedones</description>
        <time_frame>2 weeks</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Global Face Non-Inflammatory Lesion Count - Week 2</title>
          <description>Sum of open comedones and closed comedones</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Non-inflammatory Lesions</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.7" spread="15.94"/>
                    <measurement group_id="O2" value="18.3" spread="11.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Global Face Non-Inflammatory Lesion Count - Week 4</title>
        <description>Sum of open comedones and closed comedones</description>
        <time_frame>4 weeks</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Global Face Non-Inflammatory Lesion Count - Week 4</title>
          <description>Sum of open comedones and closed comedones</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Non-inflammatory lesions</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
                <count group_id="O2" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.0" spread="16.39"/>
                    <measurement group_id="O2" value="16.2" spread="10.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Global Face Non-Inflammatory Lesion Count - Week 8</title>
        <description>Sum of open comedones and closed comedones</description>
        <time_frame>8 weeks</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Global Face Non-Inflammatory Lesion Count - Week 8</title>
          <description>Sum of open comedones and closed comedones</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Non-inflammatory Lesions</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="57"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.8" spread="13.92"/>
                    <measurement group_id="O2" value="14.8" spread="10.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Global Face Non-Inflammatory Lesion Count - Week 12</title>
        <description>Sum of open comedones and closed comedones</description>
        <time_frame>12 weeks</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Global Face Non-Inflammatory Lesion Count - Week 12</title>
          <description>Sum of open comedones and closed comedones</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Non-inflammatory Lesions</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.6" spread="12.92"/>
                    <measurement group_id="O2" value="14.0" spread="13.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Global Face Total Lesion Count - Week 2</title>
        <description>Sum of inflammatory and non-inflammatory lesions</description>
        <time_frame>2 weeks</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Global Face Total Lesion Count - Week 2</title>
          <description>Sum of inflammatory and non-inflammatory lesions</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Lesions</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.8" spread="19.30"/>
                    <measurement group_id="O2" value="28.6" spread="13.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Global Face Total Lesion Count - Week 4</title>
        <description>Sum of inflammatory and non-inflammatory lesions</description>
        <time_frame>4 weeks</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Global Face Total Lesion Count - Week 4</title>
          <description>Sum of inflammatory and non-inflammatory lesions</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Lesions</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
                <count group_id="O2" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.8" spread="20.10"/>
                    <measurement group_id="O2" value="25.2" spread="13.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Global Face Total Lesion Count - Week 8</title>
        <description>Sum of inflammatory and non-inflammatory lesions</description>
        <time_frame>8 weeks</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Global Face Total Lesion Count - Week 8</title>
          <description>Sum of inflammatory and non-inflammatory lesions</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Lesions</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="57"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.7" spread="17.41"/>
                    <measurement group_id="O2" value="22.5" spread="13.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Global Face Total Lesion Count - Week 12</title>
        <description>Sum of inflammatory and non-inflammatory lesions</description>
        <time_frame>12 weeks</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Global Face Total Lesion Count - Week 12</title>
          <description>Sum of inflammatory and non-inflammatory lesions</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Lesions</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.3" spread="17.56"/>
                    <measurement group_id="O2" value="21.7" spread="17.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Investigator Global Acne Assessment - Week 1</title>
        <description>Investigator Global Acne Assessment using Modified Cooke's Scale - Week 1. Modified Cooke's scale ranges from 0 = clear/no acne to 5 = very severe acne. Half-points are allowed.</description>
        <time_frame>1 week</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Investigator Global Acne Assessment - Week 1</title>
          <description>Investigator Global Acne Assessment using Modified Cooke's Scale - Week 1. Modified Cooke's scale ranges from 0 = clear/no acne to 5 = very severe acne. Half-points are allowed.</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="64"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.29" spread="0.444"/>
                    <measurement group_id="O2" value="2.27" spread="0.427"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Investigator Global Acne Assessment - Week 2</title>
        <description>Investigator Global Acne Assessment using Modified Cooke's Scale - Week 2. Modified Cooke's scale ranges from 0 = clear/no acne to 5 = very severe acne. Half-points are allowed.</description>
        <time_frame>2 weeks</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Investigator Global Acne Assessment - Week 2</title>
          <description>Investigator Global Acne Assessment using Modified Cooke's Scale - Week 2. Modified Cooke's scale ranges from 0 = clear/no acne to 5 = very severe acne. Half-points are allowed.</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.17" spread="0.500"/>
                    <measurement group_id="O2" value="2.06" spread="0.470"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Investigator Global Acne Assessment - Week 4</title>
        <description>Investigator Global Acne Assessment using Modified Cooke's Scale - Week 4. Modified Cooke's scale ranges from 0 = clear/no acne to 5 = very severe acne. Half-points are allowed.</description>
        <time_frame>4 weeks</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Investigator Global Acne Assessment - Week 4</title>
          <description>Investigator Global Acne Assessment using Modified Cooke's Scale - Week 4. Modified Cooke's scale ranges from 0 = clear/no acne to 5 = very severe acne. Half-points are allowed.</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
                <count group_id="O2" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.00" spread="0.587"/>
                    <measurement group_id="O2" value="1.90" spread="0.583"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Investigator Global Acne Assessment - Week 8</title>
        <description>Investigator Global Acne Assessment using Modified Cooke's Scale - Week 8. Modified Cooke's scale ranges from 0 = clear/no acne to 5 = very severe acne. Half-points are allowed.</description>
        <time_frame>8 weeks</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Investigator Global Acne Assessment - Week 8</title>
          <description>Investigator Global Acne Assessment using Modified Cooke's Scale - Week 8. Modified Cooke's scale ranges from 0 = clear/no acne to 5 = very severe acne. Half-points are allowed.</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="57"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.84" spread="0.669"/>
                    <measurement group_id="O2" value="1.73" spread="0.600"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Investigator Global Acne Assessment - Week 12</title>
        <description>Investigator Global Acne Assessment using Modified Cooke's Scale - Week 12. Modified Cooke's scale ranges from 0 = clear/no acne to 5 = very severe acne. Half-points are allowed.</description>
        <time_frame>12 weeks</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Investigator Global Acne Assessment - Week 12</title>
          <description>Investigator Global Acne Assessment using Modified Cooke's Scale - Week 12. Modified Cooke's scale ranges from 0 = clear/no acne to 5 = very severe acne. Half-points are allowed.</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.64" spread="0.724"/>
                    <measurement group_id="O2" value="1.64" spread="0.589"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Overall Redness of Inflammatory Lesions - Week 1</title>
        <description>Additional investigator efficacy assessment. 0-9 scale where 0 = no redness associated with the inflammatory lesions; 9 = overall, inflammatory lesions exhibit severe degree of redness</description>
        <time_frame>1 week</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Redness of Inflammatory Lesions - Week 1</title>
          <description>Additional investigator efficacy assessment. 0-9 scale where 0 = no redness associated with the inflammatory lesions; 9 = overall, inflammatory lesions exhibit severe degree of redness</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="64"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.88" spread="1.222"/>
                    <measurement group_id="O2" value="5.05" spread="1.278"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Overall Redness of Inflammatory Lesions - Week 2</title>
        <description>Additional investigator efficacy assessment. 0-9 scale where 0 = no redness associated with the inflammatory lesions; 9 = overall, inflammatory lesions exhibit severe degree of redness</description>
        <time_frame>2 weeks</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Redness of Inflammatory Lesions - Week 2</title>
          <description>Additional investigator efficacy assessment. 0-9 scale where 0 = no redness associated with the inflammatory lesions; 9 = overall, inflammatory lesions exhibit severe degree of redness</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.65" spread="1.183"/>
                    <measurement group_id="O2" value="4.74" spread="1.202"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Overall Redness of Inflammatory Lesions - Week 4</title>
        <description>Additional investigator efficacy assessment. 0-9 scale where 0 = no redness associated with the inflammatory lesions; 9 = overall, inflammatory lesions exhibit severe degree of redness</description>
        <time_frame>4 weeks</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Redness of Inflammatory Lesions - Week 4</title>
          <description>Additional investigator efficacy assessment. 0-9 scale where 0 = no redness associated with the inflammatory lesions; 9 = overall, inflammatory lesions exhibit severe degree of redness</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
                <count group_id="O2" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.49" spread="1.291"/>
                    <measurement group_id="O2" value="4.41" spread="1.318"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Overall Redness of Inflammatory Lesions - Week 8</title>
        <description>Additional investigator efficacy assessment. 0-9 scale where 0 = no redness associated with the inflammatory lesions; 9 = overall, inflammatory lesions exhibit severe degree of redness</description>
        <time_frame>8 weeks</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Redness of Inflammatory Lesions - Week 8</title>
          <description>Additional investigator efficacy assessment. 0-9 scale where 0 = no redness associated with the inflammatory lesions; 9 = overall, inflammatory lesions exhibit severe degree of redness</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="57"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.30" spread="1.278"/>
                    <measurement group_id="O2" value="4.25" spread="1.446"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Overall Redness of Inflammatory Lesions - Week 12</title>
        <description>Additional investigator efficacy assessment. 0-9 scale where 0 = no redness associated with the inflammatory lesions; 9 = overall, inflammatory lesions exhibit severe degree of redness</description>
        <time_frame>12 weeks</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Redness of Inflammatory Lesions - Week 12</title>
          <description>Additional investigator efficacy assessment. 0-9 scale where 0 = no redness associated with the inflammatory lesions; 9 = overall, inflammatory lesions exhibit severe degree of redness</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.96" spread="1.346"/>
                    <measurement group_id="O2" value="3.97" spread="1.282"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Overall Size of Inflammatory Lesions - Week 1</title>
        <description>Additional investigator efficacy assessment. 0-9 scale where 0 = no longer visible; 9 = overall size is very large</description>
        <time_frame>1 week</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Size of Inflammatory Lesions - Week 1</title>
          <description>Additional investigator efficacy assessment. 0-9 scale where 0 = no longer visible; 9 = overall size is very large</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="64"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.58" spread="1.298"/>
                    <measurement group_id="O2" value="4.83" spread="1.371"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Overall Size of Inflammatory Lesions - Week 2</title>
        <description>Additional investigator efficacy assessment. Additional investigator efficacy assessment. 0-9 scale where 0 = no longer visible; 9 = overall size is very large</description>
        <time_frame>2 weeks</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Size of Inflammatory Lesions - Week 2</title>
          <description>Additional investigator efficacy assessment. Additional investigator efficacy assessment. 0-9 scale where 0 = no longer visible; 9 = overall size is very large</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.17" spread="1.129"/>
                    <measurement group_id="O2" value="4.56" spread="1.222"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Overall Size of Inflammatory Lesions - Week 4</title>
        <description>Additional investigator efficacy assessment. Additional investigator efficacy assessment. 0-9 scale where 0 = no longer visible; 9 = overall size is very large</description>
        <time_frame>4 weeks</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Size of Inflammatory Lesions - Week 4</title>
          <description>Additional investigator efficacy assessment. Additional investigator efficacy assessment. 0-9 scale where 0 = no longer visible; 9 = overall size is very large</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
                <count group_id="O2" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.07" spread="1.273"/>
                    <measurement group_id="O2" value="4.15" spread="1.408"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Overall Size of Inflammatory Lesions - Week 8</title>
        <description>Additional investigator efficacy assessment. Additional investigator efficacy assessment. 0-9 scale where 0 = no longer visible; 9 = overall size is very large.</description>
        <time_frame>8 weeks</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Size of Inflammatory Lesions - Week 8</title>
          <description>Additional investigator efficacy assessment. Additional investigator efficacy assessment. 0-9 scale where 0 = no longer visible; 9 = overall size is very large.</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="57"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.88" spread="1.290"/>
                    <measurement group_id="O2" value="3.85" spread="1.606"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Overall Size of Inflammatory Lesions - Week 12</title>
        <description>Additional investigator efficacy assessment. Additional investigator efficacy assessment. 0-9 scale where 0 = no longer visible; 9 = overall size is very large</description>
        <time_frame>12 weeks</time_frame>
        <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
        <group_list>
          <group group_id="O1">
            <title>Gel-Cream + Acne Mask</title>
            <description>Cleanser, Gel-Cream, Acne Mask</description>
          </group>
          <group group_id="O2">
            <title>Acne Mask</title>
            <description>Cleanser, Acne Mask</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Size of Inflammatory Lesions - Week 12</title>
          <description>Additional investigator efficacy assessment. Additional investigator efficacy assessment. 0-9 scale where 0 = no longer visible; 9 = overall size is very large</description>
          <population>Intent-to-treat population was used, including all subjects with data for this time point. The number may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.67" spread="1.305"/>
                    <measurement group_id="O2" value="3.59" spread="1.411"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events (AEs) were collected from time of informed consent through subject's last study procedure (Week 12 unless terminated early). Serious adverse events (SAE) reported to the site were also reportable within 30 days of last procedure/visit and longer if considered study-related; there was no specific cut-off date for this reporting, but AEs/SAEs are shown in this posting for a collection period of 1 year from last subject's visit (the time of this posting).</time_frame>
      <desc>The Investigator or a designee interviewed subjects for changes in health/medication at each visit, documenting any reported adverse events.</desc>
      <group_list>
        <group group_id="E1">
          <title>Gel-Cream + Acne Mask</title>
          <description>Cleanser, Gel-Cream, Acne Mask</description>
        </group>
        <group group_id="E2">
          <title>Acne Mask</title>
          <description>Cleanser, Acne Mask</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>PI must provide Sponsor 60 days to review any publication (unless expedited review requested); if includes Sponsor’s confidential info, written Sponsor approval is required. Sponsor may require another 60 days’ delay to file patent app. If multicenter, PI agrees 1st publication is joint publication. If joint publication not submitted within 24 months of study end or Sponsor confirms there will be no joint publication, PI may publish the results individually following previous guidelines.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Ali Fassih, Ph.D.</name_or_title>
      <organization>Johnson &amp; Johnson Consumer Inc.</organization>
      <phone>908-904-3259</phone>
      <email>Afassih@its.jnj.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

